American Gene Technologies®
In The News
National Institutes of Health: “Dr Roscoe Brady & Gaucher Disease”
It is with great sadness that we share the news of the passing of former National Institutes of Health scientist and American Gene Chief Scientific Advisor, Roscoe O. Brady, M.D., a pioneer of modern medicine and true public servant who improved the lives of thousands…
Read More
Medium: “Disruption for Dummies” — Why Gene Therapy Cost Estimates are Wrong”
WHY GENE THERAPY COST ESTIMATES ARE WRONG – AN OP-ED FROM AGT CEO, JEFF GALVIN Last week, a colleague and I hosted our first ever Reddit AMA and were intrigued with a question posed by one /u/marefo. So much so that I felt compelled to dive headfirst into…
Read More
Wired: “Obama’s Anti-Cancer Moonshot Will Need More Than Research”
On January 13, 2016, American Gene CEO, Jeff Galvin was asked to weigh in on Vice President Biden’s “moonshot to cure cancer”.
Read More
National Institutes of Health: “AGT Receives NIH Grant for FD Research”
NIH Grant to further Familial Dysautonomia (FD) Research ROCKVILLE, Maryland. (August 10, 2015) – American Gene Technologies International, Inc. (AGT) today announced its receipt of an NIH Grant of $230,000 to further its Familial Dysautonomia (FD) research in 2015. Get the details below: NIH Grant Details
Read More
CBS: “Baltimore Biotech CEO Continues His Education In Order To Accomplish His Life Mission”
Anyone who has experienced the death of a loved one from a terrible illness can appreciate the life mission of Mr. Jeff Galvin, CEO of American Gene Technologies (AGT). Armed with a bachelor’s degree in Economics from Harvard University, Jeff and AGT work to develop…
Read More- « Previous
- 1
- …
- 6
- 7
- 8
Subscribe to News Releases and News Updates
Subscribe to our news release and published article updates to be notified when we release new content!
Follow AGT on Social Media
AGT on Facebook
